Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dubhfeasa Slattery is active.

Publication


Featured researches published by Dubhfeasa Slattery.


American Journal of Respiratory and Critical Care Medicine | 2015

The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway

Bojana Mirković; M. Murray; Gillian M. Lavelle; Kevin Molloy; Ahmed Abdul Azim; Cedric Gunaratnam; Fiona Healy; Dubhfeasa Slattery; Paul McNally; Joe Hatch; Matthew C. Wolfgang; Michael M. Tunney; Marianne S. Muhlebach; Rosaleen Devery; Catherine M. Greene; Noel G. McElvaney

RATIONALE Anaerobic bacteria are present in large numbers in the airways of people with cystic fibrosis (PWCF). In the gut, anaerobes produce short-chain fatty acids (SCFAs) that modulate immune and inflammatory processes. OBJECTIVES To investigate the capacity of anaerobes to contribute to cystic fibrosis (CF) airway pathogenesis via SCFAs. METHODS Samples of 109 PWCF were processed using anaerobic microbiological culture with bacteria present identified by 16S RNA sequencing. SCFA levels in anaerobic supernatants and bronchoalveolar lavage (BAL) were determined by gas chromatography. The mRNA and/or protein expression of two SCFA receptors, GPR41 and GPR43, in CF and non-CF bronchial brushings and 16HBE14o(-) and CFBE41o(-) cells were evaluated using reverse transcription polymerase chain reaction, Western blot analysis, laser scanning cytometry, and confocal microscopy. SCFA-induced IL-8 secretion was monitored by ELISA. MEASUREMENTS AND MAIN RESULTS Fifty-seven (52.3%) of 109 PWCF were anaerobe positive. Prevalence increased with age, from 33.3% to 57.7% in PWCF younger (n = 24) and older (n = 85) than 6 years of age. All evaluated anaerobes produced millimolar concentrations of SCFAs, including acetic, propionic, and butyric acids. SCFA levels were higher in BAL samples of adults than in those of children. GPR41 levels were elevated in CFBE41o(-) versus 16HBE14o(-) cells; CF versus non-CF bronchial brushings; and 16HBE14o(-) cells after treatment with cystic fibrosis transmembrane conductance regulator inhibitor CFTR(inh)-172, CF BAL, or inducers of endoplasmic reticulum stress. SCFAs induced a dose-dependent and pertussis toxin-sensitive IL-8 response in bronchial epithelial cells, with a higher production of IL-8 in CFBE41o(-) than in 16HBE14o(-) cells. CONCLUSIONS This study illustrates that SCFAs contribute to excessive production of IL-8 in CF airways colonized with anaerobes via up-regulated GPR41.


Journal of Cystic Fibrosis | 2015

Outcome in patients with cystic fibrosis liver disease

Marion Rowland; Cliona Gallagher; Charles G. Gallagher; Risteárd Ó. Laoide; Gerard Canny; Annemarie Broderick; Jennifer Drummond; Peter Greally; Dubhfeasa Slattery; Leslie Daly; Noel G. McElvaney; Billy Bourke

BACKGROUND Liver disease is an important complication in CF. AIMS To determine if CFLD is a risk factor for mortality in CF, and which baseline characteristics predict all-cause mortality. METHODS Irish children with CFLD, and their age and gender matched controls were enrolled at baseline and reviewed after 10years to determine which characteristics predict mortality. RESULTS 72/84 (85.71%) participants were followed, (mean age Cases 21.71yrs SD 6.5, CF controls 23.62 SD 5.6, 22 (61%) males), with no difference in duration of follow-up. Nineteen participants (26.4%) died, 38.9% (14/36) with CFLD and 13.89% (5/36) CF controls (Odds Ratio (OR) 3.94 95% CI:1.23-12.56 p=0.005). In logistic regression, liver disease (OR 4.28 95% CI 1.07-17.16) female gender (OR 12.25 95% CI 2.37-63.24), reduced pulmonary function, (OR 5.11 95% CI 1.09-23.81) were each independent risk factors for mortality in CF. CONCLUSIONS Liver disease is an independent risk factor for mortality in CF.


Journal of Cystic Fibrosis | 2012

WS1.1 Liver disease in cystic fibrosis

Marion Rowland; Charles G. Gallagher; C.G. Gallagher; Risteard Ó'Laoide; G. Canny; Annemarie Broderick; Peter Greally; Dubhfeasa Slattery; Leslie Daly; Noel G. McElvaney; Peter R. Durie; Billy Bourke


Archive | 2011

Cystic Fibrosis liver disease: A ten year follow-up study

C L Gallagher; Charles G. Gallagher; Risteard Ó'Laoide; G. Canny; Roisin Hayes; Dubhfeasa Slattery; Peter Greally; Leslie Daly; Peter R. Durie; Annemarie Broderick; Noel G. McElvaney; Billy Bourke; Marion Rowland


Irish Medical Journal | 2015

Diagnosis and treatment of sleep related breathing disorders in children: 2007 to 2011.

A Walsh; F Phelan; M Phelan; Martin Ryan; F. Healy; Dubhfeasa Slattery; Basil Elnazir; Peter Greally; Barry Linnane; M. Ni Chroinin; David Mullane; M. Herzig; Des W. Cox; S. Javadpour; Paul McNally


ESPE 2014 | 2014

Early Detection and Treatment of Cystic Fibrosis Related Diabetes Mellitus in a Tertiary Paediatric Centre: a Case Series

Eirin Carolan; Claire Murphy; Caoimhe Howard; Dubhfeasa Slattery; Fiona Healy; Donnell Ciara Mc; Nuala Murphy


European Respiratory Journal | 2013

Prospective audit examing the resting energy expenditure (REE) of paediatric patients with CF

Marianne O Reilly; Clodagh Dempsey; Denise Moran; Mary Morgan; Dubhfeasa Slattery; Fiona Healy


american thoracic society international conference | 2012

Radiological Trends In Assessment For Cystic Fibrosis Liver Disease In Children

Prateek Shukla; Js Wagener; Eilish Twomey; Dubhfeasa Slattery


Journal of Cystic Fibrosis | 2012

259 Nutrition and lung function in a tertiary cystic fibrosis centre

N. Lagan; A. Walsh; L. Kelly; M. Morgan; F. Healy; Dubhfeasa Slattery


Journal of Cystic Fibrosis | 2012

22 Screening for cystic fibrosis related complications in a paediatric population

A. Walsh; N. Lagan; Z. Edworthy; L. Kelly; Dubhfeasa Slattery; F. Healy

Collaboration


Dive into the Dubhfeasa Slattery's collaboration.

Top Co-Authors

Avatar

Noel G. McElvaney

Royal College of Surgeons in Ireland

View shared research outputs
Top Co-Authors

Avatar

Peter Greally

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Billy Bourke

University College Dublin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Leslie Daly

University College Dublin

View shared research outputs
Top Co-Authors

Avatar

Marion Rowland

University College Dublin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul McNally

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge